Circulating tumor DNA (ctDNA) is a blood test that looks for tiny pieces of cancer DNA released by dying cells, allowing ...

Chronic illnesses like depression and cancer can affect social commitments due to unpredictable symptoms and invisible ...

The lump in my left breast was discovered by my PCP. She sent me for another mammogram, followed by a needle-core biopsy. The ...

CURE spoke with Dr. Robert Alter of John Theurer Cancer Center about the best time to explore clinical trials. For patients ...

During the Blood Cancer Heroes Event, Joe McDonough shared his excitement at being among individuals making meaningful ...

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...

“Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma,” CURE; ...

Oya Gilbert, diagnosed with myeloma in 2017, uses advocacy and music to improve awareness, access and support for patients ...

Patients share their experiences with myeloma relapses, discussing coping strategies, emotional challenges, and the ...

Results from the phase 3 EPCORE DLBCL-1 clinical trial show that patients with relapsed or refractory diffuse large B-cell ...

In attempt to assess treatment patterns in advanced gastric cancer across racial and ethnic groups throughout the U.S., ...

Patients share their personal journeys and insights on the decision-making process surrounding transplant options for cancer ...